{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:37:48Z","timestamp":1794555468963,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou Science and Technology Key Project","award":["SYWD2025394"],"award-info":[{"award-number":["SYWD2025394"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Insulin resistance (IR) is the key pathogenic factor of type 2 diabetes (T2DM) and its associated metabolic diseases. Mitochondrial dysfunction and inadequate mitophagy are central to this pathology. Curcumin, the main bioactive compound of\n                    <jats:italic>Curcuma longa<\/jats:italic>\n                    , has been reported to enhance insulin sensitivity, yet the mechanism in hepatocytes remains debated. Here we investigated whether curcumin alleviates hepatocyte IR by targeting PTEN-induced putative kinase 1 (PINK1)\/ Parkin-dependent mitophagy. We induced IR in HepG2 cells with palmitic acid (PA) and then treated with curcumin. To verify the mechanism, we used PINK1 siRNA (siPINK1) and the mitophagy blocker Mdivi-1. Glucose uptake, glycogen content, lipid accumulation, phosphatidylinositol 3-kinase (PI3K)\/ protein kinase B (Akt)\/ glucose transporter 4 (GLUT4) signaling, mitochondrial function, and mitophagy markers were quantified by flow cytometry, glycogen assay kit, Oil Red O staining, confocal imaging, and Western blot. Curcumin mitigated PA-induced IR, increased PI3K\/Akt phosphorylation and GLUT4 expression, promoted GLUT4 translocation to the plasma membrane, restored mitochondrial membrane potential and ATP content, and enhanced PINK1\/Parkin-mediated mitophagy. These effects were partially blunted by siPINK1 or Mdivi-1. In HepG2 cells, curcumin improves insulin resistance by activating PINK1\/Parkin-dependent mitophagy and rescuing mitochondrial function.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-47924-6","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:18:15Z","timestamp":1775668695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Curcumin ameliorates hepatic insulin resistance by activating PINK1\/Parkin-mediated mitophagy"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhanhong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"10397","key":"47924_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBDD Collaborators","year":"2023","unstructured":"Collaborators, G. B. D. D. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet 402 (10397), 203\u2013234 (2023).","journal-title":"Lancet"},{"key":"47924_CR2","doi-asserted-by":"publisher","first-page":"1366946","DOI":"10.3389\/fphar.2024.1366946","volume":"15","author":"MF Abdulghani","year":"2024","unstructured":"Abdulghani, M. F. & Al-Fayyadh, S. Natural products for managing metabolic syndrome: a scoping review[J]. Front. Pharmacol. 15, 1366946 (2024).","journal-title":"Front. Pharmacol."},{"key":"47924_CR3","doi-asserted-by":"crossref","unstructured":"Martiniakova, M. et al. Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus[J]. Nutrients, 17(2). (2025).","DOI":"10.3390\/nu17020275"},{"key":"47924_CR4","doi-asserted-by":"publisher","first-page":"121668","DOI":"10.1016\/j.lfs.2023.121668","volume":"322","author":"S Kumar","year":"2023","unstructured":"Kumar, S. et al. Phloretin and phlorizin mitigates inflammatory stress and alleviate adipose and hepatic insulin resistance by abrogating PPARgamma S273-Cdk5 interaction in type 2 diabetic mice[J]. Life Sci. 322, 121668 (2023).","journal-title":"Life Sci."},{"issue":"30","key":"47924_CR5","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1021\/acs.jafc.1c02476","volume":"69","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. Ginsenoside Rg5 Improves Insulin Resistance and Mitochondrial Biogenesis of Liver via Regulation of the Sirt1\/PGC-1alpha Signaling Pathway in db\/db Mice[J]. J. Agric. Food Chem. 69 (30), 8428\u20138439 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"47924_CR6","doi-asserted-by":"crossref","unstructured":"Veluthakal, R. et al. Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression[J]. Int. J. Mol. Sci., 25(3). (2024).","DOI":"10.3390\/ijms25031504"},{"issue":"1","key":"47924_CR7","doi-asserted-by":"publisher","first-page":"115203","DOI":"10.1016\/j.celrep.2024.115203","volume":"44","author":"ZG Zheng","year":"2025","unstructured":"Zheng, Z. G. et al. Ergosterol alleviates hepatic steatosis and insulin resistance via promoting fatty acid beta-oxidation by activating mitochondrial ACSL1[J]. Cell. Rep. 44 (1), 115203 (2025).","journal-title":"Cell. Rep."},{"key":"47924_CR8","doi-asserted-by":"publisher","first-page":"115928","DOI":"10.1016\/j.bcp.2023.115928","volume":"218","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Berberine protects mice against type 2 diabetes by promoting PPARgamma-FGF21-GLUT2-regulated insulin sensitivity and glucose\/lipid homeostasis[J]. Biochem. Pharmacol. 218, 115928 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"47924_CR9","doi-asserted-by":"publisher","first-page":"611323","DOI":"10.3389\/fmicb.2021.611323","volume":"12","author":"F Du","year":"2021","unstructured":"Du, F. et al. Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota[J]. Front. Microbiol. 12, 611323 (2021).","journal-title":"Front. Microbiol."},{"key":"47924_CR10","doi-asserted-by":"crossref","unstructured":"Li, L. et al. Metformin improves insulin resistance, liver healthy and abnormal hepatic glucolipid metabolism via IR\/PI(3)K\/AKT pathway in Ctenopharyngodon idella fed a high-carbohydrate diet[J]: (Comp Biochem Physiol C Toxicol Pharmacol 283, 109976.(2024).","DOI":"10.1016\/j.cbpc.2024.109976"},{"key":"47924_CR11","doi-asserted-by":"publisher","first-page":"1509045","DOI":"10.3389\/fphar.2025.1509045","volume":"16","author":"M Hao","year":"2025","unstructured":"Hao, M. et al. Pharmacological effects, formulations, and clinical research progress of curcumin[J]. Front. Pharmacol. 16, 1509045 (2025).","journal-title":"Front. Pharmacol."},{"key":"47924_CR12","doi-asserted-by":"crossref","unstructured":"Farzaei, M. H. et al. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective[J]. Nutrients, 10(7). (2018).","DOI":"10.3390\/nu10070855"},{"key":"47924_CR13","doi-asserted-by":"publisher","first-page":"106908","DOI":"10.1016\/j.prostaglandins.2024.106908","volume":"175","author":"X Zheng","year":"2024","unstructured":"Zheng, X. et al. The effect of curcumin supplementation on glycemic indices in adults: A meta-analysis of meta-analyses[J]. Prostaglandins Other Lipid Mediat. 175, 106908 (2024).","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"47924_CR14","doi-asserted-by":"publisher","first-page":"152879","DOI":"10.1016\/j.bbrc.2025.152879","volume":"790","author":"M Chen","year":"2025","unstructured":"Chen, M., Yao, J. & Liu, Z. Curcumin ameliorates high-glucose-induced lipid accumulation in HepG2 cells via AMPK activation and mTOR suppression[J]. Biochem. Biophys. Res. Commun. 790, 152879 (2025).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"47924_CR15","doi-asserted-by":"publisher","first-page":"113092","DOI":"10.1016\/j.biopha.2022.113092","volume":"151","author":"Z Jin","year":"2022","unstructured":"Jin, Z. et al. Curcumin exerts chondroprotective effects against osteoarthritis by promoting AMPK\/PINK1\/Parkin-mediated mitophagy[J]. Biomed. Pharmacother. 151, 113092 (2022).","journal-title":"Biomed. Pharmacother"},{"issue":"12","key":"47924_CR16","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca, A. et al. Mitophagy in human health, ageing and disease[J]. Nat. Metab. 5 (12), 2047\u20132061 (2023).","journal-title":"Nat. Metab."},{"issue":"1","key":"47924_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41419-025-07936-y","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies[J]. Cell. Death Dis. 16 (1), 652 (2025).","journal-title":"Cell. Death Dis."},{"key":"47924_CR18","doi-asserted-by":"crossref","unstructured":"Rustamov, N. et al. Korean Red Ginseng Improves Oxidative Stress-Induced Hepatic Insulin Resistance via Enhancing Mitophagy[J]. Foods, 13(13). (2024).","DOI":"10.3390\/foods13132137"},{"key":"47924_CR19","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.biopha.2017.11.069","volume":"97","author":"S Geng","year":"2018","unstructured":"Geng, S. et al. Curcumin suppresses JNK pathway to attenuate BPA-induced insulin resistance in LO2 cells[J]. Biomed. Pharmacother. 97, 1538\u20131543 (2018).","journal-title":"Biomed. Pharmacother"},{"issue":"4","key":"47924_CR20","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1007\/s12011-024-04314-1","volume":"203","author":"VE Sarmiento-Ortega","year":"2025","unstructured":"Sarmiento-Ortega, V. E. et al. Curcumin Treatment Ameliorates Hepatic Insulin Resistance Induced by Sub-chronic Oral Exposure to Cadmium LOAEL Dose via NF-kappaB and Nrf2 Pathways[J]. Biol. Trace Elem. Res. 203 (4), 2382\u20132393 (2025).","journal-title":"Biol. Trace Elem. Res."},{"issue":"41","key":"47924_CR21","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1021\/acs.jafc.7b02880","volume":"65","author":"J Nie","year":"2017","unstructured":"Nie, J. et al. Caffeic Acid Phenethyl Ester (Propolis Extract) Ameliorates Insulin Resistance by Inhibiting JNK and NF-kappaB Inflammatory Pathways in Diabetic Mice and HepG2 Cell Models[J]. J. Agric. Food Chem. 65 (41), 9041\u20139053 (2017).","journal-title":"J. Agric. Food Chem."},{"key":"47924_CR22","doi-asserted-by":"crossref","unstructured":"Hussain, Y. et al. How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions[J]. Molecules, 27(13). (2022).","DOI":"10.3390\/molecules27134058"},{"key":"47924_CR23","doi-asserted-by":"publisher","first-page":"1216708","DOI":"10.3389\/fendo.2023.1216708","volume":"14","author":"L Qiu","year":"2023","unstructured":"Qiu, L. et al. Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials[J]. Front. Endocrinol. (Lausanne). 14, 1216708 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"47924_CR24","doi-asserted-by":"publisher","first-page":"113015","DOI":"10.1016\/j.jep.2020.113015","volume":"259","author":"P Li","year":"2020","unstructured":"Li, P. et al. Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells[J]. J. Ethnopharmacol. 259, 113015 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"47924_CR25","doi-asserted-by":"crossref","unstructured":"Tanase, D. M. et al. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)[J]. J Diabetes Res, 2020:3920196. (2020).","DOI":"10.1155\/2020\/3920196"},{"key":"47924_CR26","doi-asserted-by":"crossref","unstructured":"Izbicka, E. & Streeper, R. T. Mitigation of Insulin Resistance by Natural Products from a New Class of Molecules. Membrane-Active Immunomodulators[J] Pharmaceuticals (Basel), 16(7). (2023).","DOI":"10.3390\/ph16070913"},{"key":"47924_CR27","doi-asserted-by":"crossref","unstructured":"Ansari, P. et al. Plant-Based Diets and Phytochemicals in the Management of Diabetes Mellitus and Prevention of Its Complications: A Review[J]. Nutrients, 16(21). (2024).","DOI":"10.3390\/nu16213709"},{"issue":"5","key":"47924_CR28","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/ptr.8463","volume":"39","author":"F Niazpour","year":"2025","unstructured":"Niazpour, F. & Meshkani, R. Unlocking the Therapeutic Potential of Autophagy Modulation by Natural Products in Tackling Non-Alcoholic Fatty Liver Disease[J]. Phytother Res. 39 (5), 2357\u20132373 (2025).","journal-title":"Phytother Res."},{"issue":"1","key":"47924_CR29","doi-asserted-by":"publisher","first-page":"114008","DOI":"10.1016\/j.yexcr.2024.114008","volume":"437","author":"F Bonanini","year":"2024","unstructured":"Bonanini, F. et al. A comparison between different human hepatocyte models reveals profound differences in net glucose production, lipid composition and metabolism in vitro[J]. Exp. Cell. Res. 437 (1), 114008 (2024).","journal-title":"Exp. Cell. Res."},{"key":"47924_CR30","doi-asserted-by":"publisher","first-page":"117931","DOI":"10.1016\/j.jep.2024.117931","volume":"327","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Activation of NRF2 by epiberberine improves oxidative stress and insulin resistance in T2DM mice and IR-HepG2 cells in an AMPK dependent manner[J]. J. Ethnopharmacol. 327, 117931 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"47924_CR31","doi-asserted-by":"crossref","unstructured":"Song, L., Li, Y. & Xu, M. Exogenous Nucleotides Ameliorate Insulin Resistance Induced by Palmitic Acid in HepG2 Cells through the IRS-1\/AKT\/FOXO1 Pathways[J]. Nutrients, 16(12). (2024).","DOI":"10.3390\/nu16121801"},{"key":"47924_CR32","doi-asserted-by":"crossref","unstructured":"Huggett, Z. J. et al. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation[J]. Nutrients, 15(1). (2022).","DOI":"10.3390\/nu15010040"},{"key":"47924_CR33","doi-asserted-by":"crossref","unstructured":"Arzumanian, V., Pyatnitskiy, M. & Poverennaya, E. Comparative Transcriptomic Analysis of Three Common Liver Cell Lines[J]. Int. J. Mol. Sci., 24(10). (2023).","DOI":"10.3390\/ijms24108791"},{"key":"47924_CR34","doi-asserted-by":"publisher","first-page":"957968","DOI":"10.3389\/fphys.2022.957968","volume":"13","author":"P Ning","year":"2022","unstructured":"Ning, P. et al. Mitophagy: A potential therapeutic target for insulin resistance[J]. Front. Physiol. 13, 957968 (2022).","journal-title":"Front. Physiol."},{"key":"47924_CR35","doi-asserted-by":"publisher","first-page":"686820","DOI":"10.3389\/fcell.2021.686820","volume":"9","author":"Z Su","year":"2021","unstructured":"Su, Z. et al. Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders[J]. Front. Cell. Dev. Biol. 9, 686820 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"47924_CR36","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.1038\/s41598-023-34710-x","volume":"13","author":"R Undamatla","year":"2023","unstructured":"Undamatla, R. et al. Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis[J]. Sci. Rep. 13 (1), 7575 (2023).","journal-title":"Sci. Rep."},{"key":"47924_CR37","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, M. & Wang, Y. Induction of Autophagy as a Therapeutic Breakthrough for NAFLD: Current Evidence and Perspectives[J]. Biology (Basel), 14(8). (2025).","DOI":"10.3390\/biology14080989"},{"key":"47924_CR38","doi-asserted-by":"publisher","first-page":"111110","DOI":"10.1016\/j.cbi.2024.111110","volume":"398","author":"J He","year":"2024","unstructured":"He, J. et al. Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation[J]. Chem. Biol. Interact. 398, 111110 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"47924_CR39","doi-asserted-by":"publisher","first-page":"1230783","DOI":"10.3389\/fphar.2023.1230783","volume":"14","author":"X He","year":"2023","unstructured":"He, X. et al. Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses[J]. Front. Pharmacol. 14, 1230783 (2023).","journal-title":"Front. Pharmacol."},{"key":"47924_CR40","doi-asserted-by":"crossref","unstructured":"Killackey, S. A., Philpott, D. J. & Girardin, S. E. Mitophagy pathways in health and disease[J]. J. Cell. Biol., 219(11). (2020).","DOI":"10.1083\/jcb.202004029"},{"key":"47924_CR41","doi-asserted-by":"crossref","unstructured":"Huang, Y. et al. Mitophagy as a pivotal axis in non\u2013alcoholic fatty liver disease: From pathogenic mechanisms to therapeutic strategies (Review)[J]. Mol. Med. Rep., 32(5). (2025).","DOI":"10.3892\/mmr.2025.13664"},{"issue":"2","key":"47924_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/MCB.05603-11","volume":"32","author":"HF Jheng","year":"2012","unstructured":"Jheng, H. F. et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle[J]. Mol. Cell. Biol. 32 (2), 309\u2013319 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"47924_CR43","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.2147\/DDDT.S327378","volume":"15","author":"Y Peng","year":"2021","unstructured":"Peng, Y. et al. Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures[J]. Drug Des. Devel Ther. 15, 4503\u20134525 (2021).","journal-title":"Drug Des. Devel Ther."},{"key":"47924_CR44","doi-asserted-by":"publisher","first-page":"1548073","DOI":"10.3389\/fphar.2025.1548073","volume":"16","author":"J Cui","year":"2025","unstructured":"Cui, J. et al. Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway[J]. Front. Pharmacol. 16, 1548073 (2025).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47924-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:38:48Z","timestamp":1781645928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47924"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47924-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16667"}}